Acute myeloid leukemia-Major progress over four decades and glimpses into the future
نویسندگان
چکیده
منابع مشابه
Disquieting uncertainty. Three glimpses into the future
The article sketches three major realms the realm of world order, the realm of work, and the realm of social policy that will in all likelihood undergo fundamental change in the years and decades ahead, raising deeply unsettling questions about their future. The account is framed by the concept of global modernity, which, while not spelled out in detail, guides the presentation of data and othe...
متن کاملChronic Myelogenous Leukemia-Progress at the M. D. Anderson Cancer Center over the Past Two Decades and Future Directions: First
The purpose of this study was to review the progress in clinical and translational research in chronic myelogenous leukemia (CML) over the past 20 years at M. D. Anderson Cancer Center. The CML database updating the clinical and basic research investigations was reviewed as the source of this report. Publications resulting from these investigations were summarized. The long-term results with in...
متن کاملMajor progress in understanding progression in chronic myeloid leukemia
At last, a mouse model of the natural history of chronic myeloid leukemia (CML) has been elegantly engineered. CML is hardly a public health menace, occurring in only 1–2 per 100,000 people. Nonetheless, the disease is the " poster child " of genetically based diagnosis and treatment, as all cases of CML have the BCR-ABL trans-location, which is both a diagnostic marker of the disease and a tar...
متن کاملThe role of microRNA in acute/chronic, myeloid/lymphocytic leukemia
MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...
متن کاملCancer and leukemia group B breast committee: decades of progress and plans for the future.
The Breast Committee of the Cancer and Leukemia Group B was formed in 1969 under the direction of James Holland. Initial studies examined combination chemotherapy for advanced disease. Although the committee has continued to conduct studies in patients with advanced disease, adjuvant therapy has been an even more important focus for the past 30 years. Over the past 20 years, studies have focuse...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hematology
سال: 2015
ISSN: 0361-8609
DOI: 10.1002/ajh.24246